Epoxy-Keto Derivative of Linoleic Acid Stimulates Aldosterone Secretion

Hypertension

Volumn 43, Issue 2, 2004, Pages 358-363

  Goodfriend, Theodore L ^a   Ball, Dennis L ^a   Egan, Brent M ^a   Campbell, William B ^a   Nithipatikom, Kasem ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Adrenal gland; Aldosterone; Fatty acids; Hypertension; Obesity; Oxidative stress

Indexed keywords

12,13 EPOXY 9 KETO 10 OCTADECENOIC ACID; ANGIOTENSIN; ARACHIDONIC ACID; ATRIAL NATRIURETIC FACTOR; CORTICOSTEROID; FATTY ACID DERIVATIVE; LINOLEIC ACID; POLYUNSATURATED FATTY ACID; POTASSIUM; PREGNENOLONE; RENIN; UNCLASSIFIED DRUG;

ADRENAL CELL; ADULT; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE RELEASE; ANIMAL CELL; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; FEMALE; HUMAN; HYPERTENSION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NEGRO; NONHUMAN; OBESITY; OXIDATIVE STRESS; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RAT; STEROIDOGENESIS; SYSTOLIC BLOOD PRESSURE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALDOSTERONE; ANIMALS; CELLS, CULTURED; HUMANS; LINOLEIC ACID; MIDDLE AGED; OBESITY; OLEIC ACIDS; RATS; ZONA GLOMERULOSA;

EID: 0842333052     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.0000113294.06704.64     Document Type: Article

References (31)

1. Quinn SJ, Williams GH. Regulation of aldosterone secretion. Am Rev Physiol. 1988; 50: 409-426.
2. Ehrhart-Bornstein M, Hinson J, Bornstein S, Scherbaum W, Vinson G. Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr Rev. 1998; 19: 101-143.
3. Brown RD, Wisgerhof M, Carpenter PC, Brown G, Jiang NS, Kao P, Hegstad R. Adrenal sensitivity to angiotensin II and undiscovered aldosterone stimulating factors in hypertension. J of Steroid Biochem. 1979; II: 1043-1050.
4. Campbell DJ, Increased steroidogenesis by rat zona glomerulosaa cells with increased cell concentration in vitro: evidence for a novel aldosterone-stimulating factor and implications regarding aldosterone biosynthesis. J Endocr. 1982; 94: 225-241.
5. O’Brien MJ, Levell MJ, Hullin RP. Inhibition of aldosterone production in adrenal cell suspensions by serum from patients with manic-depressive psychosis. J Endocr. 1979; 80: 41-50.
6. Goodfriend TL, Egan BM, Kelley DE. Aldosterone in obesity. Endocr Res. 1998; 24: 789-796.
7. Keaney JF Jr., Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, Massaro JM, Sutherland P, Vita JA, Benjamin EJ; Framingham Study. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol. 2003; 23: 434-439.
8. Prabha PS, Das UN, Koratkar R, Sagar PS, Ramesh G. Free radical generation, lipid peroxidation and essential fatty acids in uncontrolled essential hypertension. Prostaglandins Leukot Essent Fatty Acids. 1990; 41: 27-33.
9. Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD. Measurement of plasma glucose, free fatty acids, lactate, and insulin for 24 hours in patients with NIDDM. Diabetes. 1998; 37: 1020-1024.
10. Fagot-Campagna A, Balkau B, Simon D, Warnet JM, Claude JR, Ducimetiere P, Eschwege E. High free fatty acid concentration: an independent risk factor for hypertension in the Paris Prospective Study. Internat J Epidemiol. 1998; 27: 808-813.
11. Goodfriend TL, Ball DL, Gardner HW. An oxidized derivative of linoleic acid affects aldosterone secretion by adrenal cells in vitro. Prostaglandins Leukot Essent Fatty Acids. 2002; 67: 163-167.
12. 3 catalyst as a model for similar biochemical reactions. II. Specificity in formation of fatty acid epoxides. Biochim Biophys Acta. 1981; 665: 113-125.
13. Gardner, HW. Analysis of plant lipoxygenase metabolites. In Christie WW, ed. Advances in Lipid Methodology - Four. Dundee, Scotland: The Oily Press; 1997: 1-44.
14. Nithipatikom K, Grall AJ, Holmes BB, Harder DR, Falck JR, Campbell WB. Liquid chromatographic-electrospray ionization-mass spectrometric analysis of cytochrome P450 metabolites of arachidonic acid. Anal Biochem. 2001; 298: 327-336.
15. Goodfriend TL, Ball DL, Elliott ME, Shackleton C. Lead increases aldosterone production by rat adrenal cells. Hypertension. 1995; 25: 785-789.
16. Lopes HF, Martin KL, Nashar K, Morrow JD, Goodfriend TL, Egan BM. DASH diet lowers blood pressure and lipid-induced oxidative stress in obesity. Hypertension. 2003; 41: 422-430.
17. Lopes HF, Morrow JD, Stoijiljkovic MP, Goodfriend TL, Egan BM. Acute hyperlipidemia increases oxidative stress more in African Americans than in white Americans. AM J Hypertens. 2003; 16: 331-336.
18. Frankel EN. Lipid Oxidation. Dundee, Scotland: The Oily Press, Ltd;. l998.
19. Greene J. Surging demand for specialists spurs salary hikes. Am Med News October 22/29, 2001, Vol 44, Number 40 page 1.
20. Brash AR. Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate. J Biol Chem. 1999; 274: 23679-23682.
21. Bruder ED, Ball DL, Goodfriend TL, Raff H. An oxidized metabolite of linoleic acid stimulates corticosterone production by rat adrenal cells. Am J Physiol: Regul Integr Comp Physiol. 2003; 284: R1631-R1635.
22. Elliot ME, Goodfriend TL. Inhibition of aldosterone synthesis by atrial natriuretic factor. Fed Proc. 1986; 41: 574-578.
23. Goodfriend TL, Ball DL, Elliott ME, Chabhi A, Duong T, Raff H, Schneider EG, Brown RD, Weinberger MH. Fatty acids may regulate aldosterone secretion and mediate some of insulin’s effects on blood pressure. Prostaglandins Leukot Essent Fatty Acids. 1993; 48: 43-50.
24. Stern N, Yanagawa K, Natarajan R, Tuck ML, Nadler JL. Potential role of 12-hydroxyeicosatetraenoic in angiotensin II-induced calcium signal in rat glomerulosa cells. Endocrinology. 1993; 133: 843-847.
25. Engler MM, Schambelan M, Engler MB, Ball DL, Goodfriend TL. Effects of dietary γ-linolenic acid on blood pressure and adrenal angiotensin receptors in hypertensive rats. Proc Soc Exp Biol Med. 1998; 218: 234-237.
26. Engler MM, Engler MB, Goodfriend TL, Ball DL, Yu Z, Su P, Kroetz DL. Docosahexaenoic acid is an antihypertensive nutrient that affects aldosterone productions in SHR. Proc Soc Exp Biol Med. 1999; 221: 32-38.
27. Perticone F, Ceravolo R, Candigliota M, Ventura G, Iacopine S, Sinopoli F, Mattioli PL. Obesity and body fat distribution induce endothelial dysfunction by oxidative stress. Diabetes. 2001; 50: 159-165.
28. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, Chayama K. Endothelial function and oxidative stress in renovascular hypertension. New England J Med. 2002; 346: 1954-1962.
29. Romero J, Reckelhoff J. Role of angiotensin and oxidative stress in essential hypertension. Hypertension. 1999; 34: 943-949.
30. Vasiri ND, Liang K, Ding Y. Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension. Kidney Int. 1999; 56: 1492-1498.
31. Weber KT. Aldosterone in congestive heart failure. N Engl J Med. 2001; 345: 1689-1697.